These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19273265)

  • 41. Redox signaling in heart failure and therapeutic implications.
    Weissman D; Maack C
    Free Radic Biol Med; 2021 Aug; 171():345-364. PubMed ID: 34019933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
    Xu Q; Dalic A; Fang L; Kiriazis H; Ritchie RH; Sim K; Gao XM; Drummond G; Sarwar M; Zhang YY; Dart AM; Du XJ
    Br J Pharmacol; 2011 Mar; 162(5):1012-28. PubMed ID: 20955367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NADPH oxidase and heart failure.
    Murdoch CE; Grieve DJ; Cave AC; Looi YH; Shah AM
    Curr Opin Pharmacol; 2006 Apr; 6(2):148-53. PubMed ID: 16483850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
    Gang C; Qiang C; Xiangli C; Shifen P; Chong S; Lihong L
    J Pharm Pharm Sci; 2015; 18(2):235-48. PubMed ID: 26158288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes.
    Sabri A; Hughie HH; Lucchesi PA
    Antioxid Redox Signal; 2003 Dec; 5(6):731-40. PubMed ID: 14588146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NADPH oxidases in heart failure: poachers or gamekeepers?
    Zhang M; Perino A; Ghigo A; Hirsch E; Shah AM
    Antioxid Redox Signal; 2013 Mar; 18(9):1024-41. PubMed ID: 22747566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failure.
    Guo WT; Dong DL
    Heart Fail Rev; 2014 Nov; 19(6):781-8. PubMed ID: 24736806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IDH2 deficiency promotes mitochondrial dysfunction and cardiac hypertrophy in mice.
    Ku HJ; Ahn Y; Lee JH; Park KM; Park JW
    Free Radic Biol Med; 2015 Mar; 80():84-92. PubMed ID: 25557279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.
    Huang Q; Zhou HJ; Zhang H; Huang Y; Hinojosa-Kirschenbaum F; Fan P; Yao L; Belardinelli L; Tellides G; Giordano FJ; Budas GR; Min W
    Circulation; 2015 Mar; 131(12):1082-97. PubMed ID: 25628390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cardiac L-type calcium channel alpha subunit is a target for direct redox modification during oxidative stress-the role of cysteine residues in the alpha interacting domain.
    Muralidharan P; Cserne Szappanos H; Ingley E; Hool LC
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():46-54. PubMed ID: 28306174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissecting the role of redox signaling in neuronal development.
    Bórquez DA; Urrutia PJ; Wilson C; van Zundert B; Núñez MT; González-Billault C
    J Neurochem; 2016 May; 137(4):506-17. PubMed ID: 26875993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.
    Liu C; Cao F; Tang QZ; Yan L; Dong YG; Zhu LH; Wang L; Bian ZY; Li H
    J Nutr Biochem; 2010 Dec; 21(12):1238-50. PubMed ID: 20185286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thioredoxin and ventricular remodeling.
    Ago T; Sadoshima J
    J Mol Cell Cardiol; 2006 Nov; 41(5):762-73. PubMed ID: 17007870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of adrenergic receptor in H9c2 cardiac myoblasts co-stimulates Nox2 and the derived ROS mediate the downstream responses.
    Saleem N; Goswami SK
    Mol Cell Biochem; 2017 Dec; 436(1-2):167-178. PubMed ID: 28593564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.